Authors:
Re, G
Badino, P
De Angelis, I
Odore, R
Belloli, C
Citation: G. Re et al., Identification and coupling to adenylate cyclase of three different [H-3]CGP 12177 binding sites in Caco-2 cell membranes, PHARMAC RES, 43(4), 2001, pp. 393-398
Authors:
Turco, L
De Angelis, I
Stammati, A
Zucco, F
Citation: L. Turco et al., Apoptosis evaluation in epithelial cells exposed to different chemicals: relevance of floating cells, CELL BIOL T, 16(1), 2000, pp. 53-62
Authors:
Eeckhoutte, C
Larrieu, G
Sutra, JF
Alvinerie, M
Mace, K
Pfeifer, A
Zucco, F
Stammati, AL
De Angelis, I
Vignoli, AL
Galtier, P
Citation: C. Eeckhoutte et al., Evidence for cytochrome P4501A2-mediated protein covalent binding of thiabendazole and for its passive intestinal transport: use of human and rabbit derived cells, CHEM-BIO IN, 127(2), 2000, pp. 109-124
Authors:
Klee, S
Baumung, I
Kluge, K
Ungemach, FR
Horne, E
O'Keeffe, M
De Angelis, I
Vignoli, AL
Zucco, F
Stammati, A
Citation: S. Klee et al., A contribution to safety assessment of veterinary drug residues: in vitro/ex vivo studies on the intestinal toxicity and transport of covalently bound residues, XENOBIOTICA, 29(6), 1999, pp. 641-654
Authors:
De Angelis, I
Rossi, L
Pedersen, JZ
Vignoli, AL
Vincentini, O
Hoogenboom, LAP
Polman, THG
Stammati, A
Zucco, F
Citation: I. De Angelis et al., Metabolism of furazolidone: alternative pathways and modes of toxicity in different cell lines, XENOBIOTICA, 29(11), 1999, pp. 1157-1169